Vivos Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2024: USD 581.00 K

Vivos Therapeutics, Inc. Depreciation And Amortization is USD 581.00 K for the Trailing 12 Months (TTM) ending December 31, 2024, a -6.44% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Vivos Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 621.00 K, a -7.17% change year over year.
  • Vivos Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 669.00 K, a -8.73% change year over year.
  • Vivos Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 733.00 K, a 2.11% change year over year.
  • Vivos Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 717.87 K, a -4.44% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased